Non Small Cell Lung Cancer

Antifolates show promise against NSCLC subtype

Patients with non-small cell lung cancer who have mutations in the KRAS gene should respond well to the antifolate class of drugs, according to results of a recent study conducted by Quintiles comparing human lung cancer ...